Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial
Author(s):
I. Russel Lee, Steven Y.C. Tong, Joshua S. Davis, David L. Paterson, Sharifah F. Syed-Omar, Kwong Ran Peck, Doo Ryeon Chung, Graham S. Cooke, Eshele Anak Libau, Siti Nabilah B.A. Rahman, Mihir P. Gandhi, Luming Shi, Shuwei Zheng, Jenna Chaung, Seow Yen Tan, Shirin Kalimuddin, Sophia Archuleta, David C. Lye
Details:
Trials, Volume 23, Issue 1, 2022-12-01, Article number 572
Article Link: Click here
Affiliations:
- Sengkang General Hospital
- National Centre for Infectious Diseases
- School of Medicine and Public Health
- Lee Kong Chian School of Medicine
- The Peter Doherty Institute for Infection and Immunity
- UQ Centre for Clinical Research
- Duke-NUS Medical School
- National University Hospital
- NUS Yong Loo Lin School of Medicine
- Samsung Medical Center, Sungkyunkwan university
- Singapore General Hospital
- Imperial College London
- University of Malaya Medical Centre
- Changi General Hospital
- Tan Tock Seng Hospital
- Consortium for Clinical Research and Innovation
- Ng Teng Fong General Hospital